Jason L. Haw, Elizabeth M. Moore, Kimberly McKinney, Karl Dykema, Abhinav Nagulapally, Nury Steuerwald, Giselle S. Sholler. 9-ING-41, a glycogen synthase kinase 3B inhibitor targets TP53 in pediatric brain tumors ATRT and ETMR, (2022), Proceedings of the 113th Annual Meeting of the American Association for Cancer Research; 2021 April 8-13; New Orleans LA. Philadelphia (PA): AACR; [...]

Giselle L. Saulnier Sholler, Dan G. Duda, Genevieve Bergendahl, David Ebb, Matija Snuderl, Theodore W. Laetsch, Jennifer Michlitsch, Derek Hanson, Michael Isakoff, Kevin Bielamowicz, Jacquline Kraveka, Peter Carmeliet, Andy De Deene, Rakesh K. Jain, A phase 1 dose escalation study of TB-403 in pediatric relapsed or refractory medulloblastoma, neuroblastoma, Ewing sarcoma, or alveolar rhabdomyosarcoma, Proceedings of the [...]

Smith, K, Gandra, D, McKinney, K, Dykema, K, Nagulapally, A, Sholler, GS, Oesterheld, J, Trovillion, E.  Identification of targeted therapies for treatment of Ewing sarcoma [abstract].  In: Proceedings of the 113th Annual Meeting of the American Association for Cancer Research; 2021 April 8-13; New Orleans LA. Philadelphia (PA): AACR; 2022. Abstract nr 3980

Abhinav B Nagulapally, Karl Dykema, Javier Oesterheld, William Ferguson, Michael Isakoff, Erin Trovillion, Genevieve Bergendahl, Giselle Saulnier Sholler, Genomic Comparative Analysis of High Risk Neuroblastoma at Diagnosis and Relapse, ASPHO Annual Meeting, Poster Presentation, April 2021 Portland, OR (Virtual)

Kristin L. Leskoske, Sara A. Byron, Seema Plaisier, Apurva M. Hegde, Krystine Garcia-Mansfield, Ritin Sharma, Genevieve Bergendahl, Abhinav B. Nagulapally, William Ferguson, Jaqueline Kraveka, Javier Oesterheld, William P.D. Hendricks, Giselle L. Saulnier Sholler, Jeffrey M. Trent, Patrick Pirrotte Integrated proteomic analysis identifies four distinct subtypes of high-risk neuroblastoma, In: Proceedings of the 113th Annual Meeting of the American [...]

Giselle Saulnier Sholler, Dan G. Duda, Genevieve Bergendahl, David Ebb, Matija Snuderl, Theodore W. Laetsch, Jennifer Michlitsch, Derek Hanson, Michael S. Isakoff, Kevin Bielamowicz, Jacqueline Kraveka, Peter Carmeliet, Andy De Deene, Rakesh K. Jain A phase 1 dose escalation study of TB-403 in pediatric relapsed or refractory medulloblastoma, neuroblastoma, Ewing sarcoma or alveolar rhabdomyosarcoma, Oral Platform [...]

Virginia L. Harrod, MD, PhD, Abhinav B. Nagulapally, MS, Elizabeth C. Lewis, Giselle Saulnier Sholler, MD Feasibility and applicability of molecular guided therapy in high grade glioma/diffuse midline glioma: Results from Beat Childhood Cancer NMTRC-009 Molecular Guided Therapy study. ISPNO 2020, Japan (Virtual)

Austin Goodyke, Shannon Kelly, Joseph Zagorski, Elizabeth VanSickle, Tyler Maser, Caryl Sortwell, Christopher Kemp, Abhinav Nagulapally, Karl Dykema, Giselle Saulnier-Sholler Targeting Lin28 in ETMR with ODC1 inhibitor DFMO, ISPNO 2020, Japan (Virtual)

Giselle L. Saulnier Sholler, Jacqueline M. Kraveka, William Ferguson, Genevieve Bergendahl, William P. D. Hendricks, Abhinav Nagulapally, Sara A. Byron, James Lowey, William Burleson, Elizabeth VanSickle, Muhammed Murtaza, Matija Snuderl, Timothy J Triche Jr, and Jeffrey M. Trent. A collaborative pediatric cancer precision medicine model leveraging shared genomic, clinical, and research data from high-risk solid tumor [...]

Jacqeline Kraveka, Valerie Brown, William Ferguson, Genevieve Bergendahl, William Roberts, Jessica Foley, Deanna Mitchell, Javier Oesterheld, Michael Isakoff, Kathleen Neville, Randal Wada, Jawhar Rawwas, Gina Hanna, Abhinav Beeravally Nagulapally, Jeffrey Bond, Jeffrey Trent, William Hendricks, Sarah Byron, Giselle Sholler. Peds-PLAN, pediatric precision laboratory advanced neuroblastoma therapy: Molecular guided therapy for high risk neuroblastoma at diagnosis, Advances [...]